- Home
- SHEN vs CATX Comparison
SHEN vs CATX Comparison
Compare SHEN & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHEN
- CATX
- Stock Information
- Founded
- SHEN 1902
- CATX 1983
- Country
- SHEN United States
- CATX United States
- Employees
- SHEN N/A
- CATX N/A
- Industry
- SHEN Telecommunications Equipment
- CATX Medical/Dental Instruments
- Sector
- SHEN Telecommunications
- CATX Health Care
- Exchange
- SHEN Nasdaq
- CATX Nasdaq
- Market Cap
- SHEN 769.1M
- CATX 782.7M
- IPO Year
- SHEN N/A
- CATX N/A
- Fundamental
- Price
- SHEN $12.89
- CATX $11.79
- Analyst Decision
- SHEN Strong Buy
- CATX Strong Buy
- Analyst Count
- SHEN 1
- CATX 9
- Target Price
- SHEN $26.00
- CATX $21.63
- AVG Volume (30 Days)
- SHEN 224.3K
- CATX 845.1K
- Earning Date
- SHEN 11-07-2024
- CATX 11-12-2024
- Dividend Yield
- SHEN 0.78%
- CATX N/A
- EPS Growth
- SHEN 5257.28
- CATX N/A
- EPS
- SHEN 3.75
- CATX N/A
- Revenue
- SHEN $328,807,000.00
- CATX $1,464,000.00
- Revenue This Year
- SHEN $19.26
- CATX N/A
- Revenue Next Year
- SHEN $20.54
- CATX N/A
- P/E Ratio
- SHEN $3.43
- CATX N/A
- Revenue Growth
- SHEN 19.28
- CATX 78.32
- 52 Week Low
- SHEN $11.87
- CATX $2.20
- 52 Week High
- SHEN $24.32
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- SHEN 40.11
- CATX 42.62
- Support Level
- SHEN $13.76
- CATX $11.40
- Resistance Level
- SHEN $16.28
- CATX $12.82
- Average True Range (ATR)
- SHEN 0.81
- CATX 0.61
- MACD
- SHEN -0.01
- CATX 0.06
- Stochastic Oscillator
- SHEN 19.86
- CATX 26.00
About SHEN Shenandoah Telecommunications Co
Shenandoah Telecommunications Company, with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through two business units: tower and broadband. The tower segment leases company-owned cell tower spaces to other wireless communication providers, while the broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.